Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein

Clinical trial NCT02465801 · COMPLETED

Trial details

NCT number: NCT02465801
Sponsor: Tianjin SinoBiotech Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia

Start date: 2014-12-16
Primary completion: 2015-12-23
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.